The new line incorporates integrated sound-dampening materials to reduce noise both within and outside the kennels both for the patients and clinical teams.
It also features a proprietary antibacterial polymer and toughened safety-glass doors, which Casco says improve biosecurity and support more efficient cleaning protocols.
According to Casco, testing has shown CareKennels take around 40% less time to clean than stainless-steel cages.
Casco Pet CEO Matthew Bubear said: "CareKennels bring together many of the strengths our products are known for - design quality, thoughtful construction and a wellness-first approach - while offering an accessible option for clinics looking to improve their housing standards."
"Creating calmer, more comfortable spaces for patients supports better clinical outcomes as well as contributing to a more positive working environment for veterinary professionals."
https://cascopet.com
The plan includes a redesigned digital experience to give members access to BSAVA clinical resources and the launch of LUMOS, which is billed as a new, modern, flexible CPD programme and platform.
The Association is also developing its AI-powered search tool call Rover, which will help clinicians navigate BSAVA resources at the point of care, including the Formulary, Manuals and Library content.
A redesigned BSAVA mobile app is also in the pipeline, along with regional and digital community spaces to help members stay connected between events.
Stacy Woodman, Interim CEO of the BSAVA, said: "The small animal veterinary profession is evolving rapidly, and the BSAVA must evolve with it.
"Our new strategy focuses on making knowledge, learning and professional support easier to access throughout a veterinary professional's career."
She added: "We're revitalising our simple but powerful premise of 'the profession supporting the profession' and are encouraging our members to share their views by taking part in our ongoing Membership Survey and helping to create a BSAVA for the future."
https://research.potentia-insight.co.uk/survey/selfserve/53b/2602105?list=1
The documents, provided to VetSurgeon by a whistleblower from within IVC, reveal the company's plans to stop issuing prescriptions and replace them with a new Pre-Scription service.
IVC Pre-Scriptions will include:
VetSurgeon understands that Pre-Scriptions will be charged at £85.68
The whistleblower also shared a draft public price list which the company is said to be preparing in anticipation of the CMA’s proposed requirement for practices to publish pricing information online.
The leaked price list includes entries for first consultations, repeat consultations, out-of-hours consultations, nurse consultations, nail clipping, anal gland expression, microchipping, animal health certificates, primary and booster vaccinations, kennel cough vaccination, pet care plans, prescription and dispensing fees, dental work, neutering procedures, physiotherapy, laser therapy, diagnostic imaging, blood tests, euthanasia and cremation.
At first glance, many of the prices shown in the draft appear surprisingly low.
Among the figures listed are:
First consultation: £5
Repeat consultation: £4
Nurse consultation: £3
Nail clipping: £1
Anal gland expression: £2
Microchipping: £2
Booster vaccination: £2
MRI scan (per body part): £7
CT scan (per body part): £6
VetSurgeon contacted Intrepid Veterinary Care for comment.
Company spokesperson Dr Flora Olip MRCVS said the group was “committed to embracing the spirit of transparency while continuing to innovate in client experience”.
She said: “The proposed CMA remedies create an important opportunity for veterinary businesses to present pricing clearly and consistently. We believe pet owners deserve not only transparent pricing, but also choice.
“The Pre-Scription offer is not a prescription fee.
"It is a wider premium service built around documentation, presentation and client convenience, within which a prescription may be provided.”
The leaked document also included indicative pricing for procedures not listed on the CMA-mandated price list, including TPLO surgery, which is listed at 'fixed cost price' of £4,475,000.
Among the programme highlights is "Managing complaints post-CMA, what do you need to know?", featuring BVA President Rob Williams, Jennie Jones, Head of Veterinary Client Mediation Service, and Gavin Durston, Director of Thrums Vets.
In another session, "Hot topic: CMA remedies - what do they mean in practice?", Rob Williams, Kate Higgins, owner and Director of Village Vets Formby, and Lyndsay Hughes, BVNA Senior Vice President, will debate where we are with the investigation, what comes next, and the possible impact of the CMA remedies on practices.
The programme also includes sessions on clinical practice, leadership in the workplace and the role of vets in ethical decision making.
Clinical stream highlights include euthanasia in small mammals, birds and reptiles, anaesthesia in comorbid patients, updates in ocular pharmacology, optimizing hospital care for long-term patients, and managing anxiety in "pandemic puppies".
The BVA Interactive Zone will also return, with President Rob Williams, Senior Vice President Elizabeth Mullineaux and Junior Vice President Gwen Rees leading debates on overtreatment, managing and improving a toxic workplace and contextualised care.
Rob said: "As the profession emerges from the CMA investigation, BVA Live will be one of the first opportunities for vet teams to come together to access practical CPD to move forwards and comply with the CMA remedies."
https://bvalive.vetshow.com/conference-programme
The course, which has been produced as part of Dechra's collaboration with Not One More Vet, is presented by vets who specialise in mental health counselling.
The four new topics are: client communication: the human side of veterinary medicine; professional identity development for students and recent graduates; executive function management and mental health; and the science of mindfulness.
https://academy.dechra.com/learn/catalog/view/502
The new hydrolysed diet contains hydrolysed proteins, AuraGuard, fibres and Zeolite.
Dechra says the new formula featured in both diets offers superior palatability and works in a multi-action way with support of the gut-kidney axis to help optimise protein absorption and maintenance of muscle mass, gut barrier integrity and a healthy microbiome, while lowering uremic toxins in the blood.
The company says both diets control levels of protein, phosphorus and sodium and offer high levels of the Omega-3 fatty acids EPA and DHA.
Becky Morris, marketing manager at Dechra, said: "Chronic kidney disease is a lifelong progressive disease in dogs and cats, and nutrition is an important part of management to help slow disease progression, improve quality of life and reduce the risk of secondary complications.
"Our new and updated highly palatable Specific Heart & Kidney Support diets will help keep dogs and cats in good condition, prolonging the progression of the disease and the lifespan of the pet."
https://www.specific-diets.co.uk
The drug monographs in Part A were revised and updated by the Editorial Panel during 2025, and new monographs include citalopram, enflicoxib, ilunocitinib and verdinexor.
Part A also denotes drugs available as extemporaneous products, also called "veterinary specials", as VSP in the formulations section of the monographs.
Additional content in Part A includes information on drugs used for the management of urinary incontinence, while the Appendix now includes a seizure algorithm, guidance on supplements and nutraceuticals, and expanded information on contrast agents.
There are also 7 new client information leaflets in Part A, including bezafibrate, chloramphenicol, clomipramine and memantine.
Part B covers mammals, birds, reptiles, amphibians and fish, and its drug monographs were reviewed and updated by the Editorial Panel during 2025 under Editor-in-Chief Joanna Hedley.
New monographs in Part B include afoxolaner, atorvastatin and danofloxacin, and emergency drug doses for rabbits, rodents, ferrets, birds and reptiles have been added to the inside front cover.
Part B also adds Appendix information on barium and iodinated contrast agents for diagnostic imaging, and includes client information leaflets on inhaled medications, injectable medications, oral medications, topical ear medications and topical eye medications.
Additional information on proprietary fish medicines and drug doses for different species of British wildlife, including badgers, deer, foxes and hedgehogs, is available via the BSAVA library.
Eligible BSAVA members will receive a printed copy of Part A: Canine and Feline as part of their membership from April 2026 onwards, while all BSAVA members will have access to the online version via the BSAVA library and the BSAVA app from mid-April.
Printed copies are available for £37.70 for BSAVA members and £58.00 for non-members.
https://bsavaportal.bsava.com/s/store#/store/browse/cat/a0w8d000000Mh3FAAS/tiles
Krka says Prazemo is the first generic to offer this combination of actives in this format, and is bioequivalent to the originator product.
Prazemo is available in three dosage strengths for different cat weights and can be used from 8 weeks of age and during pregnancy and lactation.
For cats that also require ectoparasiticide treatment, it can be used alongside a mono-isoxazoline (fluralaner) treatment.
Will Ridgway, Head of Animal Health at Krka UK, said: "Prazemo strengthens our feline parasiticide portfolio with an effective spot-on solution that veterinary practices can be confident delivers affordability combined with Krka’s high standards of product efficacy and supply chain control."
For more information, email: animalhealth.uk@krka.biz
Seats are available for both registered veterinary nurses and student veterinary nurses, with applications open until Friday 15th May 2026.
BVNA Council approved the move towards an Application and Selection Process last year.
It said the change was made "with the aims of promoting inclusivity, and the ability to select Council members with varying backgrounds, skills and experience, to represent a wider range of RVNs and SVNs".
Council members serve a three-year period, with terms of office staggered.
Council meets six times per year, twice at the BVNA Head Office in Harlow, once during BVNA Congress in Telford, and otherwise online.
There are three committees within BVNA Council: Congress and Events, Membership, and Policy.
Council members also represent BVNA at veterinary events, including BVNA Congress.
BVNA President Sarah Holliday said: "At a time when the veterinary profession as a whole is navigating both challenges but also significant opportunities, BVNA is committed to providing leadership and a clear voice for veterinary nurses.
"Our activities rely on having a strong Council team to guide the association, and we are delighted to invite applications from both RVN and SVN members."
https://bvna.org.uk
Dignipets says that as well as supporting clients, referring this aspect of care to qualified counsellors can also reduce the emotional strain on veterinary teams.
Last year, Dignipets launched a free app for pet carers that offers quality of life scoring tools and a connection with the Dignipets hospice team.
Dignipets says that the app can strengthen the relationship between vet practices and their clients, in a partnership where the vet team provides the best care for the pet, Dignipets provides specialist hospice support and QOL guidance, and the APBC offers professional emotional support for clients, reflecting a more holistic model of veterinary care.
Merel Taal, Founder and Principal Director at Dignipets, said: "Coping with the loss of a pet can be extremely difficult and there is no shame in seeking professional support to get through such a challenging time.
"But what really excites me is that we can now reach pet carers so much sooner - before loss, during those incredibly hard weeks and months of anticipatory grief.
"This is an amazing extra feature that means we hopefully get more pet carers struggling with anticipatory grief the support that they need - sooner."
https://www.dignipets.co.uk
The funds were raised through donations from dog owners who accessed the team's on-site service during the event.
One of the team, Rita Johnson RVN, said: "After learning about the challenges facing veterinary teams in Ukraine, the Crufts volunteer vet team wanted to support this appeal to help them continue their vital work."
Mark Johnston, Vice President of the Prosalus Foundation, said: "We were deeply moved to receive this generous donation from the volunteer vet team at Crufts.
"We thank them for their concern for veterinary teams in Ukraine and the millions of animals caught up in the conflict."
He added: "We hope more vets in the UK will follow their example and help us to help our dedicated Ukrainian colleagues through these desperate times."
UK veterinary professionals can support the campaign by donating veterinary medicines, equipment and supplies, making a cash donation online via The ProSalus Foundation's website, or bidding in a silent auction of Ukrainian art.
www.prosalusfoundation.org
The first episode features equine veterinary surgeon Fiona Farmer, BreathEazy Director and veterinary surgeon Jon Slattery, and international event rider Harry Meade.
They discuss the impact respiratory health can have on performance horses and the practical management of respiratory challenges in competition settings.
The opening episode also focuses on the relationship between respiratory health, performance and recovery, and on how veterinary understanding can inform everyday horse management.
The episode also explores the science behind nebulisation, and Jon Slattery discusses its role in administering medications and in broader respiratory management in horses exposed to dust, pollen and other environmental particles.
Fiona said: "By combining veterinary knowledge with real-world experience from the top of the sport, we hope to share useful insights that riders, owners and vets can apply."
https://open.spotify.com/episode/7FHQ6XRR3VYUawgH6sppsP
Caroline uses the five domains framework — nutrition, physical environment, health, behavioural interactions and mental state — to provide welfare assessments to help owners navigate some of the increasingly difficult choices that modern veterinary medicine now offers.
In particular, Pet Lighthouse aims to bridge the gap between Dr. Google and clinical reality, to support informed decision-making, and to give clients the long consultations that they may need to process difficult news, which may be difficult to provide in general practice.
Caroline, who has over 15 years experience in first-opinion work and eight years as the RSPCA's Chief Vet, does not prescribe or treat, and clients are directed back to their local practice for clinical care.
She said: "I am here to ensure that when a family returns to your consulting room, they are informed, calm, and focused."
"My goal is to support the profession by providing the intensive advocacy and client support that a standard consultation window simply cannot accommodate."
Caroline is inviting practices to signpost clients directly to the Pet Lighthouse website or reach out for an initial discussion.
www.petlighthouse.co.uk
Julia Albright, MA, DVM, DACVB, and Martha G. Cline, DVM, DACVIM (Nutrition) will share the latest insights on how nutrition influences behaviour, cognition, and learning in dogs and cats.
https://events.purinainstitute.com/login/purinainstitute/CollaborativeCare-2026
The charge was that between June and October 2022, the vet imported or arranged for the importation of approximately 1950 to 2010 tablets of a medicine which purported to be norethisterone when there had been no Special Importation Certificate (SIC) issued by the VMD.
The vet was also charged with supplying or arranging the supply of the medicine to a number of greyhound trainers, with a view to the medicine being administered to greyhounds.
Finally, the vet was also charged that he knew there was no SIC, that the medicine contained substances other than norethisterone, that he had made no assessment of whether any or all of the other substances were appropriate for administration to the greyhounds, and that the Greyhound Board of Great Britain did not permit greyhounds to race with the other substances found in the medicine in their system.
The vet admitted all the charges against him at the start of the hearing.
The Committee said aggravating factors included risk of injury to an animal or human, recklessness, and break of client trust.
It also noted that despite his practice being rated 4 out of 5 in a 2025 Veterinary Practice Premises Inspection Report in relation to the VMD’s most recent inspection of his practice, the report raised four matters relating to the issuing and labelling of medication.
In mitigation, the Committee accepted that the vet had imported the norethisterone from India with good intentions, in that he believed he was assisting the greyhounds to keep them racing.
It also noted that while this was not an isolated incident, he only ordered the norethisterone twice and supplied it over a five-month period in 2022.
He had also practised without incident since importing and supplying the norethisterone.
The Committee decided that the conduct amounted to serious professional misconduct, and that he had breached sections 1.5, 6.4 and 6.5 of the Code of Practice for Veterinary Surgeons in 2022.
Deciding the sanction, the Committee also noted that the vet had a previous disciplinary finding against him relating to findings of dishonesty regarding his communications with the Animal and Plant Health Agency in the taking of blood samples for horses due to be exported to Serbia, which resulted in a six-month suspension from the Register.
Neil Slater, chairing the committee, said a six-month suspension would allow the vet time to “develop insight and understanding of the importance of regulatory compliance” and reflect on his practice, while also signalling to the profession and the public that such compliance is essential.
He said the committee had considered whether removal from the register was warranted, particularly given a previous similar disciplinary finding, but concluded that this could be “career ending”. A longer suspension was also ruled out on the same basis.
However, the committee expressed significant concern that the case, alongside the earlier finding, demonstrated a “persistent disregard for regulatory legislation”. It said the sanction imposed was necessary to protect animal welfare and maintain confidence in the profession.
The vet will be suspended for six months following the expiry of the appeal period.
https://www.rcvs.org.uk/veterinary-professionals/conduct-and-guidance/concerns-for-veterinary-professionals/disciplinary-committee-hearings
Serotonin has been implicated in several canine diseases, including myxomatous mitral valve disease, pulmonary hypertension and dilated cardiomyopathy, but direct measurement in blood is challenging because of its short half-life in serum.
In humans, urinary 5‑HIAA is considered a more accurate marker of serum serotonin concentration.
However, whilst urine 5-HIAA has previously been measured in dogs using gas chromatography mass spectrometry and high-performance liquid chromatography with electrochemical detection, these techniques are expensive and not widely available.
For the study, which was funded by BSAVA PetSavers and published in the Journal of Small Animal Practice, researchers collected urine samples from 26 dogs undergoing routine diagnostic evaluation at a referral hospital.
Each sample was analysed using both a commercially available ELISA testing kit, BA-E-1900 from Immusmol, and liquid chromatography-tandem mass spectrometry, the current gold standard method.
The ELISA was found to be reliable with acceptable precision and repeatability, particularly at low concentrations, although it had a slightly higher observed error at higher concentrations.
The researchers recommended further validation work to improve understanding of the various preanalytical factors that may influence measurement of 5-HIAA concentrations.
They also said further work should investigate whether measuring urinary 5-HIAA will be a good surrogate marker for physiologically active circulating serotonin in dogs, and whether it will be useful in studying disease pathogenesis.
Dr Penny Watson, senior author of the study, said: "I am very hopeful that, after further validation, this ELISA will prove to be a reliable, simple and cheap test for 5-HIAA in the urine, facilitating further research into the role of serotonin in the pathogenesis of canine diseases.
"We have long suspected that some individual dogs and breeds may have higher circulating serotonin than others and that this might predispose them not only to heart disease but also some common diseases such as chronic pancreatitis and kidney disease.
"They would also be more susceptible to serotinergic syndrome when medicated with drugs such as tramadol or trazadone.
"Further research in this area would thus be directly relevant to small animal practitioners."
https://onlinelibrary.wiley.com/doi/10.1111/jsap.70123
Krka says Robexera injectable acts within an hour, has a 24-hour duration and that its high COX-2 selectivity reduces wider systemic impact.1
The company says that in cats, the perioperative case is particularly strong, pointing to research which it says showed robenacoxib to have the best proven safety profile in cats of all NSAIDs.1
Krka adds that it is also highly effective in reducing post-operative pain, with evidence of superior efficacy to meloxicam,2 and a proven anaesthetic-sparing effect during feline surgery.3
Will Ridgway, Head of Animal Health at Krka UK, said: “Practices want product assurance and commercial value. As a bioequivalent to the originator product,4 Robexera injectable delivers both."
https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_3090863.PDF
References
For the research, published in Osteoarthritis and Cartilage, the team studied osteoarthritic tissues from dogs with osteoarthritis treated with total hip replacement surgery at the RVC's Queen Mother Hospital for Animals, using ultra-high-resolution micro-computed tomography to map the entire femoral head in three dimensions.
Using this technique, as opposed to more localised analysis previously conducted on human samples, researchers identified that different areas of the femoral head simultaneously responded differently.
In particular, the findings revealed that in the earliest stages of osteoarthritis, the inner regions predictably change their bone structure pattern, allowing early identification of osteoarthritis.
As the disease progresses, the dense layer of bone immediately below the joint surface becomes more porous in proportion to the increasing severity of osteoarthritis, distinguishing mild from severe changes.
The researchers say that the next step is to match these changes with clinical scans to develop improved non-invasive approaches to assessing joint health at much earlier stages of disease.
Professor Richard Meeson, Professor of Orthopaedics at the RVC, and senior author of the paper, said: "Osteoarthritis is a devastating disease affecting both people and our pets.
"Every day in our orthopaedic referral clinic, I see dogs suffering from its severe effects.
"What is truly exciting is that through our clinical work, we can transform the lives of dogs through hip replacement surgery, and we have also been able to drive forward pioneering research at the RVC.
"This research has provided new insights into the disease and, crucially, brings us closer to diagnosing osteoarthritis at a much earlier stage."
Reference
The study, led by Svenja Springer from the Department of Interdisciplinary Life Sciences, Messerli Research Institute, University of Veterinary Medicine Vienna, used an online questionnaire in March 2022 to investigate dog and cat owners in Austria, Denmark and the UK, with a final sample of 2,117 owners.
The survey found that differences in insurance uptake across income groups were seen only in the UK, where 65.6% of owners in the high-income group (more than £44,800 a year) had insurance compared with only 35.1% in the low-income group (less than £22,400 a year).
Overall, 51.5% of UK households in the sample had insurance and 48.5% did not.
Among owners without insurance, UK respondents were much more likely to say policies were too expensive (48.9%) compared with 28.1% in Denmark and 29.9% in Austria.
However, when it comes to how much owners are prepared to spend on veterinary treatment, the paper concludes that emotional attachment to a pet was the most important factor, over and above income or insurance status.
Nevertheless, only around 20% of UK dog owners said they would spend over £3000 of their own money — that is, over and above any insured sum — on treatment.
Some 24.8% of the owners of uninsured dogs and 34.7% of the owners of insured dogs said they would spend £101 to £1000 of their own money.
Around 11% said they would spend £1001 - £3000 and 19.8% of insured vs 27.1% of uninsured said they didn't know.
In the first report1, which concerned an outbreak on a busy competition yard after the introduction of a new horse without an isolation period or pre-movement blood ELISA screening for recent S. equi exposure, no horses developed signs of strangles after the second vaccination with Strangvac was administered.
In the second report2 strangles was confirmed in three unvaccinated and unwell horses and 17 healthy horses on the same yard were subsequently vaccinated with Strangvac.
Blood samples in this group of vaccinated horses demonstrated that over half had recent exposure to S. equi, despite which, none of them developed strangles.
Bex Glasgow, veterinary surgeon and equine veterinary advisor at Dechra said: “Strangles vaccination, alongside good biosecurity measures, are essential tools in disease prevention and recent studies have also demonstrated its protective effect during outbreak situations.”
Strangles Awareness Week, which is supported by Dechra, takes place from 4 to 10 May 2026.
The initiative is aimed at increasing screening throughout the year and helping identify cats living with untreated hypertension.
Challenge 20 encourages vet professionals to screen and record over 20 new feline blood pressure measurements per practice in cats at increased risk, including those with concurrent diseases such as chronic kidney disease and hyperthyroidism, those with signs of target organ damage and all cats over seven years of age.
After the feedback session, the Ceva vet will work with the practice to identify any training requirements and create a tailored plan, before repeating the challenge to track progress and fine-tune the approach.
Ceva is also providing marketing materials focusing on hidden hypertension and concurrent disease, including a cat owner poster, leaflet, owner email content and a social media toolkit.
The company is also offering dedicated time and guidance from its territory managers to help implement better screening protocols.
A feline hypertension bitesize video CPD series is also available at the Ceva Academy: https://ceva.vbms-training.co.uk
Andrew Fullerton, senior product manager at Ceva, said: "Over 1,200 cats were screened during Ceva's 2025 feline hypertension campaign and a third of them were identified as hypertensive1."
He added: "We continue to encourage vet professionals to test for feline hypertension in all cats over seven years of age, with a particular focus on those more susceptible to high blood pressure, such as those with concurrent diseases and those with signs of target organ damage through our Challenge 20 initiative."
https://easethepressure.co.uk
The clinical team at the RVC analysed anonymised clinical data from dogs from the UK, Europe and the USA undergoing mitral valve repair at the Queen Mother Hospital for Animals at the RVC.
One study evaluated the anaesthetic management and outcomes of 176 dogs undergoing surgery, focusing on complications during and around the time of anaesthesia1.
The second study assessed 66 dogs to identify features on heart scans that could help predict whether the heart would remain enlarged after surgery2.
The findings showed that mitral valve repair is associated with significant intraoperative and postoperative risks.
Longer cardiopulmonary bypass duration was associated with increased risk.
Dogs with greater pre-surgical heart enlargement and higher body weight were more likely to have persistent left heart enlargement after surgery.
Close perioperative monitoring and rapid-response protocols were found to be essential in managing anticipated complications.
The study also found that recovery outcomes vary, meaning individual patient factors must be considered when advising owners.
Finally, the research demonstrated that most beneficial changes in heart size, known as reverse remodelling, occurred within the first three months after surgery.
Professor Dan Brockman, Professor in Small Animal Surgery and Director of the Cardiothoracic Surgery Service at the RVC, said: "Establishing and maintaining open heart surgical capability at the RVC has been both the most challenging and the most rewarding activity of my 36 years as a specialist small animal surgeon.
"Our team are rightly proud of what we have achieved, but we all know that the route to even greater consistency of results lies in the constant process of reflection, refinement and improvement in every aspect of what we do."
The RVC is currently the only centre in the UK offering this specialist surgical procedure.
https://www.rvc.ac.uk/small-animal-vet/specialist-referrals/advanced-techniques/cardiothoracic-surgery/mitral-valve-disease
The software is designed to help practice managers plan rotas across roles including vets, nurses, receptionists and support staff.
Agilio says that iTeam Rota can help practices spot staffing gaps earlier, manage leave, sickness and CPD on a single screen, and give team members access to an up-to-date rota from any device.
The company also says the system can support repeatable shift patterns and multi-site rota management.
Emma Barnes, Managing Director of Emerging Markets at Agilio (pictured), said: "Anyone who's ever wrestled a rota in a spreadsheet knows that sinking feeling when you've just got it straight, and then someone changes their hours or calls in sick and you're back to square one.
"It's a constant firefight, and never a finished job."
"We've built iTeam Rota specifically for veterinary practices because their staffing challenges are unlike other sectors, and generic tools simply don't cope with that.
"Practices are dealing with more part-time roles, flexible working patterns and multi-site teams, and need a rota system that mirrors how their people actually work, and not the other way round."
agiliosoftware.com/veterinary/iteam-rota
The six-month group coaching scheme is for experienced equine vets and vet nurses and is delivered through monthly online group coaching sessions.
Applications for the 2026 cohort are open until Wednesday 27 May 2026, and 25 places are available.
The coaching team includes Lucy Grieve, Claire Goodban, Kate Blakeman and Gemma Dransfield—all veterinary professionals with coaching training—now joined by vet nurse Rosina Lillywhite to give dedicated support for veterinary nurses.
Kate Blakeman, BEVA vice president, programme founder and a Back in the Saddle coach, said: "Coaching is becoming increasingly recognised as a key factor in building professional resilience, restoring confidence and supporting career transitions."
Rosina Lillywhite said: "Back in the Saddle is about creating the time and space for both vets and veterinary nurses to step back, reflect and move forward with renewed confidence."
"Whether someone is navigating a period of change or simply reassessing their direction, the programme offers structured support, practical strategies and the reassurance that they're not alone in the challenges they're facing. It's a really valuable opportunity to reconnect with your career and regain a sense of purpose within the profession."
https://www.beva.org.uk/Career-support/Vets/Back-in-the-Saddle
Cellular haemoglobin concentration mean gives clinicians a direct measurement of the average haemoglobin concentration within individually analysed red blood cells.
Unlike mean corpuscular haemoglobin concentration, which is a calculated value, cellular haemoglobin concentration mean is measured optically, which Zoetis says provides a more reliable indicator needed when a patient is anaemic and when endogenous interferents, such as haemolysis, are present.
The expansion also includes plateletcrit (PCT) measurement.
Plateletcrit provides the volume percentage of blood occupied by platelets – functionally similar to how haematocrit (HCT) reflects the red blood cell fraction.
Zoetis says PCT helps clinicians better assess platelet production, consumption, and evidence of destruction.
Both new parameters are expected to be available to Vetscan OptiCell users in 2026.
https://www.zoetisdiagnostics.com/uk